BMAL1-dependent regulation of the mTOR signaling pathway delays aging

Rohini V Khapre1, Anna A Kondratova, Sonal Patel

  • 1Center for Gene Regulation in Health and Diseases, BGES, Cleveland State University, Cleveland, OH.

Aging
|February 1, 2014
PubMed

Insights

The circadian clock

Area of Science:

  • Chronobiology
  • Molecular Biology
  • Aging Research

Background:

  • The circadian clock regulates physiological processes, but its role in aging is not fully understood.
  • BMAL1, a core circadian clock component, is crucial for lifespan and preventing premature aging.
  • Molecular mechanisms linking the circadian clock to aging remain largely unknown.

Purpose of the Study:

  • To investigate the molecular mechanisms by which the circadian clock influences aging.
  • To determine the role of BMAL1 in regulating aging pathways.
  • To explore the connection between BMAL1, mTORC1 signaling, and lifespan.

Main Methods:

  • Assessing mTORC1 activity in BMAL1-deficient mice and cell cultures.
  • Utilizing BMAL1 knockout (Bmal1-/-) mouse models.
  • Administering the mTORC1 inhibitor rapamycin to Bmal1-/- mice.

Main Results:

  • BMAL1 deficiency leads to increased mammalian Target of Rapamycin Complex 1 (mTORC1) signaling.
  • Increased mTOR signaling correlates with accelerated aging phenotypes.
  • Rapamycin treatment extended the lifespan of Bmal1-/- mice by 50%.

Conclusions:

  • BMAL1 acts as a negative regulator of mTORC1 signaling.
  • The circadian clock, via BMAL1, modulates mTOR pathway activity.
  • This BMAL1-dependent regulation of mTOR is vital for controlling aging and metabolism.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K